Specifically, cells that were co-cultured with hUCBCSc exhibited enhanced anti-tumor response to the abovementioned inhibitors and exhibited a reduction in EGFR phosphorylation and a 50% reduced expression of EGFR, c-MET, β-catenin, and STAT-3. The gene discussed is EGFR; the disease is neoplasm.